Skip to main content
Top
Published in: Archives of Osteoporosis 1/2023

01-12-2023 | Osteoporosis | Original Article

Network analysis of osteoporosis provides a global view of associated comorbidities and their temporal relationships

Authors: Hyun Il Lee, Siyeong Yoon, Jin Hwan Kim, Wooyeol Ahn, Soonchul Lee

Published in: Archives of Osteoporosis | Issue 1/2023

Login to get access

Abstract

Summary

We performed comorbidity-network analysis to obtain global view of comorbidity related with osteoporosis. We selected 10000-patients with osteoporosis registered in the National-Health-Insurance Service cohort-database. We found 45-significant disease-clusters. Of these, 14-disease-clusters were related to fra, while 10 were related to musculoskeletal diseases. Our findings will serve as basic data for further studies.

Purpose

Osteoporosis causes devastating fractures; however, its exact etiology remains unknown. Elucidating associated comorbidities and their temporal relationships could provide better insights into its pathogenesis. Comorbidity-network analysis was performed to obtain global view of these associations.

Methods

We randomly selected 10000-patients with osteoporosis registered in the National-Health-Insurance Service cohort-database. These patients were identified using ICD-10 codes M81-M82, which represent osteoporosis without pathological fractures. Control group was created through propensity score matching. The comorbidities in each group were grouped into similar classifications to form “disease cluster”; 126 such clusters were identified. To create a comorbidity network, we selected disease clusters with high associations (i.e., odds ratios and relative risks ranked in the upper 50th percentile). To identify the temporal relationships between these clusters and osteoporosis, trajectories of directions were identified.

Results

Finally, we found 45 significant disease clusters. Of these, 14 disease clusters were related to fractures or injuries, while 10 were related to musculoskeletal diseases. Temporal analysis revealed that 15 disease clusters preceded osteoporosis; these included the following three with the strongest associations: “other fracture”, “disorders of bone density and structure (M83–M85)”, and “sequelae of injuries of neck and trunk (T91)”. Thirty disease clusters followed osteoporosis; these included the following three with the strongest associations: “spine fracture,” “spondylopathies (M45–M49)”, and “pelvic region and thigh fracture,”.

Conclusion

We obtained a global view of the osteoporosis comorbidity network, which is otherwise difficult to achieve through study of individual diseases. Our findings will serve as the basic data for further studies.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ben-Shlomo Y, Kuh D (2002) A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 31:285–293CrossRefPubMed Ben-Shlomo Y, Kuh D (2002) A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 31:285–293CrossRefPubMed
3.
go back to reference Aguado A, Moratalla-Navarro F, Lopez-Simarro F, Moreno V (2020) MorbiNet: multimorbidity networks in adult general population. Analysis of type 2 diabetes mellitus comorbidity. Sci Rep 10:2416CrossRefPubMedPubMedCentral Aguado A, Moratalla-Navarro F, Lopez-Simarro F, Moreno V (2020) MorbiNet: multimorbidity networks in adult general population. Analysis of type 2 diabetes mellitus comorbidity. Sci Rep 10:2416CrossRefPubMedPubMedCentral
4.
go back to reference Khan A, Uddin S, Srinivasan U (2018) Comorbidity network for chronic disease: A novel approach to understand type 2 diabetes progression. Int J Med Inform 115:1–9CrossRefPubMed Khan A, Uddin S, Srinivasan U (2018) Comorbidity network for chronic disease: A novel approach to understand type 2 diabetes progression. Int J Med Inform 115:1–9CrossRefPubMed
5.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475CrossRefPubMed Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475CrossRefPubMed
6.
go back to reference Kim KH, Lee K, Ko YJ, Kim SJ, Oh SI, Durrance DY, Yoo D, Park SM (2012) Prevalence, awareness, and treatment of osteoporosis among Korean women: The Fourth Korea National Health and Nutrition Examination Survey. Bone 50:1039–1047CrossRefPubMed Kim KH, Lee K, Ko YJ, Kim SJ, Oh SI, Durrance DY, Yoo D, Park SM (2012) Prevalence, awareness, and treatment of osteoporosis among Korean women: The Fourth Korea National Health and Nutrition Examination Survey. Bone 50:1039–1047CrossRefPubMed
7.
go back to reference Wang P, Abdin E, Shafie S, Chong SA, Vaingankar JA, Subramaniam M (2019) Estimation of Prevalence of Osteoporosis Using OSTA and Its Correlation with Sociodemographic Factors, Disability and Comorbidities. Int J Environ Res Public Health 16 Wang P, Abdin E, Shafie S, Chong SA, Vaingankar JA, Subramaniam M (2019) Estimation of Prevalence of Osteoporosis Using OSTA and Its Correlation with Sociodemographic Factors, Disability and Comorbidities. Int J Environ Res Public Health 16
8.
go back to reference Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882CrossRefPubMed Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882CrossRefPubMed
9.
go back to reference Adami G, Saag KG (2019) Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis. Curr Rheumatol Rep 21:34CrossRefPubMed Adami G, Saag KG (2019) Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis. Curr Rheumatol Rep 21:34CrossRefPubMed
10.
go back to reference Crepaldi G, Maggi S (2009) Epidemiologic link between osteoporosis and cardiovascular disease. J Endocrinol Invest 32:2–5PubMed Crepaldi G, Maggi S (2009) Epidemiologic link between osteoporosis and cardiovascular disease. J Endocrinol Invest 32:2–5PubMed
11.
go back to reference Lopez-Medina C, Molto A (2020) Comorbidity management in spondyloarthritis. RMD Open 6 Lopez-Medina C, Molto A (2020) Comorbidity management in spondyloarthritis. RMD Open 6
12.
go back to reference Austin PC (2011) An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivar Behav Res 46:399–424CrossRef Austin PC (2011) An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivar Behav Res 46:399–424CrossRef
13.
14.
go back to reference Zhu X, Gerstein M, Snyder M (2007) Getting connected: analysis and principles of biological networks. Genes Dev 21:1010–1024CrossRefPubMed Zhu X, Gerstein M, Snyder M (2007) Getting connected: analysis and principles of biological networks. Genes Dev 21:1010–1024CrossRefPubMed
15.
go back to reference Hanauer DA, Ramakrishnan N (2013) Modeling temporal relationships in large scale clinical associations. J Am Med Inform Assoc 20:332–341CrossRefPubMed Hanauer DA, Ramakrishnan N (2013) Modeling temporal relationships in large scale clinical associations. J Am Med Inform Assoc 20:332–341CrossRefPubMed
16.
go back to reference Kim JH, Son KY, Shin DW, Kim SH, Yun JW, Shin JH, Kang MS, Chung EH, Yoo KH, Yun JM (2016) Network analysis of human diseases using Korean nationwide claims data. J Biomed Inform 61:276–282CrossRefPubMed Kim JH, Son KY, Shin DW, Kim SH, Yun JW, Shin JH, Kang MS, Chung EH, Yoo KH, Yun JM (2016) Network analysis of human diseases using Korean nationwide claims data. J Biomed Inform 61:276–282CrossRefPubMed
17.
go back to reference Sinigaglia L, Nervetti A, Mela Q et al (2000) A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis J Rheumatol 27:2582–2589 Sinigaglia L, Nervetti A, Mela Q et al (2000) A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis J Rheumatol 27:2582–2589
18.
go back to reference Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 53:1759–1766CrossRefPubMed Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 53:1759–1766CrossRefPubMed
19.
go back to reference Ziegelasch M, Forslind K, Skogh T, Riklund K, Kastbom A, Berglin E (2017) Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year. Arthritis Res Ther 19:195CrossRefPubMedPubMedCentral Ziegelasch M, Forslind K, Skogh T, Riklund K, Kastbom A, Berglin E (2017) Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year. Arthritis Res Ther 19:195CrossRefPubMedPubMedCentral
20.
go back to reference Mori Y, Kuwahara Y, Chiba S, Kogre A, Baba K, Kamimura M, Itoi E (2017) Bone mineral density of postmenopausal women with rheumatoid arthritis depends on disease duration regardless of treatment. J Bone Miner Metab 35:52–57CrossRefPubMed Mori Y, Kuwahara Y, Chiba S, Kogre A, Baba K, Kamimura M, Itoi E (2017) Bone mineral density of postmenopausal women with rheumatoid arthritis depends on disease duration regardless of treatment. J Bone Miner Metab 35:52–57CrossRefPubMed
21.
go back to reference Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286:E686–E696CrossRefPubMed Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286:E686–E696CrossRefPubMed
22.
go back to reference Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ (2001) Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998–2003CrossRefPubMed Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ (2001) Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998–2003CrossRefPubMed
23.
go back to reference Schneider DL, Barrett-Connor EL, Morton DJ (1994) Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen. JAMA 271:1245–1249CrossRefPubMed Schneider DL, Barrett-Connor EL, Morton DJ (1994) Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen. JAMA 271:1245–1249CrossRefPubMed
24.
go back to reference La Vignera S, Vicari E, Tumino S, Ciotta L, Condorelli R, Vicari LO, Calogero AE (2008) L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history. Minerva Ginecol 60:475–484PubMed La Vignera S, Vicari E, Tumino S, Ciotta L, Condorelli R, Vicari LO, Calogero AE (2008) L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history. Minerva Ginecol 60:475–484PubMed
25.
go back to reference Lin SY, Lin CL, Chen HT, Kao CH (2018) Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study. Curr Med Res Opin 34:805–812CrossRefPubMed Lin SY, Lin CL, Chen HT, Kao CH (2018) Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study. Curr Med Res Opin 34:805–812CrossRefPubMed
26.
go back to reference Appetecchia M (2005) Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study. Horm Res 64:293–298PubMed Appetecchia M (2005) Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study. Horm Res 64:293–298PubMed
27.
go back to reference Baldini M, Gallazzi M, Orsatti A, Fossati S, Leonardi P, Cantalamessa L (2002) Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size. J Intern Med 251:407–414CrossRefPubMed Baldini M, Gallazzi M, Orsatti A, Fossati S, Leonardi P, Cantalamessa L (2002) Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size. J Intern Med 251:407–414CrossRefPubMed
28.
go back to reference De Rosa G, Testa A, Maussier ML, Calla C, Astazi P, Albanese C (1995) A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre. Horm Metab Res 27:503–507CrossRefPubMed De Rosa G, Testa A, Maussier ML, Calla C, Astazi P, Albanese C (1995) A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre. Horm Metab Res 27:503–507CrossRefPubMed
29.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
30.
go back to reference Puth MT, Klaschik M, Schmid M, Weckbecker K, Munster E (2018) Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord 19:144CrossRefPubMedPubMedCentral Puth MT, Klaschik M, Schmid M, Weckbecker K, Munster E (2018) Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord 19:144CrossRefPubMedPubMedCentral
31.
go back to reference Liao CY, Chung CH, Chu P, Wei KY, Feng TM, Lin FH, Tsao CH, Wu CC, Chien WC (2018) Increased risk of osteoporosis in patients with primary biliary cirrhosis. PloS One 13:e0194418CrossRefPubMedPubMedCentral Liao CY, Chung CH, Chu P, Wei KY, Feng TM, Lin FH, Tsao CH, Wu CC, Chien WC (2018) Increased risk of osteoporosis in patients with primary biliary cirrhosis. PloS One 13:e0194418CrossRefPubMedPubMedCentral
32.
go back to reference Lygrisse KA, Roof MA, Keitel LN, Callaghan JJ, Schwarzkopf R, Bedard NA (2020) The Inaccuracy of ICD-10 Coding in Revision Total Hip Arthroplasty and Its Implication on Revision Data. J Arthroplasty 35:2960–2965.e3CrossRefPubMed Lygrisse KA, Roof MA, Keitel LN, Callaghan JJ, Schwarzkopf R, Bedard NA (2020) The Inaccuracy of ICD-10 Coding in Revision Total Hip Arthroplasty and Its Implication on Revision Data. J Arthroplasty 35:2960–2965.e3CrossRefPubMed
Metadata
Title
Network analysis of osteoporosis provides a global view of associated comorbidities and their temporal relationships
Authors
Hyun Il Lee
Siyeong Yoon
Jin Hwan Kim
Wooyeol Ahn
Soonchul Lee
Publication date
01-12-2023
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2023
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-023-01290-2

Other articles of this Issue 1/2023

Archives of Osteoporosis 1/2023 Go to the issue